GOLDMAN SACHS GROUP INC - TRANSGENOMIC INC ownership

TRANSGENOMIC INC's ticker is TBIO and the CUSIP is 89365K305. A total of 24 filers reported holding TRANSGENOMIC INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TRANSGENOMIC INC
ValueSharesWeighting
Q3 2016$3,000
-62.5%
10,735
-28.4%
0.00%
Q2 2016$8,000
-83.3%
14,996
-54.6%
0.00%
Q1 2015$48,000
-20.0%
33,052
+10.8%
0.00%
Q4 2014$60,00029,8370.00%
Other shareholders
TRANSGENOMIC INC shareholders Q1 2015
NameSharesValueWeighting ↓
Potomac Capital Management, Inc. 423,907$424,0000.46%
Trellus Management Company, LLC 196,600$283,0000.34%
WHITE PINE CAPITAL LLC 456,225$657,0000.27%
Blue Clay Capital Management, LLC 175,000$252,0000.13%
EQUITEC SPECIALISTS, LLC 78,400$113,0000.03%
Third Security, LLC 770,490$1,110,0000.03%
ARDSLEY ADVISORY PARTNERS LP 25,000$36,0000.01%
WOLVERINE ASSET MANAGEMENT LLC 56,560$81,0000.00%
Hudson Bay Capital Management LP 37,800$55,0000.00%
WELLS FARGO & COMPANY/MN 45,282$66,0000.00%
View complete list of TRANSGENOMIC INC shareholders